- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02456272
Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study (PARCO)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Otosclerosis is the main cause of acquired hearing loss in young to middle aged Caucasian population. Social, personal and medico-economic impacts triggered by this affection make it a major public health matter. Historically, the surgical treatment of otosclerosis has always been considered one of the best indications of otologic surgery. The external hearing aid was then an alternative to surgery considered as a more restrictive and less effective management of otosclerosis. With the recent technological developments of hearing aids, comparing these two treatments otosclerosis should be studied. The absence of scientific data from the literature concerning this subject justifies this study which purpose is to describe the evolution of the quality of life and hearing performance of a same patient after taking over by these two approaches.
This is a French pilot study in the Toulouse University Hospital that will include a minimum of 30 patients with proven unilateral or asymmetric otosclerosis. Each one will receive a hearing aid for a minimum of 2 months and then undergo otosclerosis surgery.
The primary outcome will be based on a study of the quality of life (score of 0-100 to quality of life validated questionnaire Glasgow Health Status Inventory (GHSI)). The questionnaire will be given to the patient at the pre-enrollment visit, after a period of two months of external hearing aid trying and 2 months after the surgery. Secondary outcomes will be studied: simple hearing performance (voice and tone audiogram), complex hearing performance (speech audiogram in noise recognition stamp), specific questionnaires for hearing (SSQ), for hearing aids (APHAB, GBI equipment), for tinnitus if present (THI and VAS discomfort / intensity) or for surgical treatment (surgery GBI). Data about treatment's side effects and the number of potential patients refusing surgery after testing the hearing aid will also be collected.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Toulouse, France, 31059
- Toulouse University Hospital (CHU de Toulouse)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Nosological criteria:
- Unilateral or bilateral asymmetric otosclerosis
- Conductive hearing loss of at least 30 dB with an average loss Rinne means greater than or equal to 20 dB (on frequencies 0.5, 1, 2, 4 kHz)
- Normal tympanum
- Temporal bones CT-scan showing radiologic signs of otosclerosis
Related to treatment criteria:
• No previous treatment for the otosclerosis
Exclusion Criteria:
Disease's related criteria:
- Far advanced otosclerosis defined as less than 95dB air conduction at all frequencies or lower bone conduction 55dB on at least one frequency
- Cochlear otosclerosis objectified on the temporal bones Ct-scan
- Others clinical or radiological diagnostics: cholesteatoma, tympanic membrane perforation, geyser's syndrome, ossicular dislocation, ossicular malformation, tympanosclerosis.
Associated pathologies: tympanic retraction, effects of chronic otitis, tubal dysfunction.
Criteria about proposed treatments:
- Anesthesia contraindications
- Operative contraindication: clotting disorders, tympanum retraction and tubal dysfunction, geyser's syndrome, single ear, patient refusal.
Criteria relative to study's explorations: Language barrier (questionnaires, tests), cognitive disorders.
Criteria relating to previous treatment: Previous hearing aid or surgery Administrative criteria: Patients minors, incapable adults, adults under guardianship, incapable of giving consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: External hearing aid & Otosclerosis surgery
Trying an hearing aid for at least two months and then undergo otosclerosis surgery
|
The external hearing aid (monaural) with an auditory prosthesis contour type, brand PHONAK type Bolero Q70 will be provided to the patients during a minimum of 2 months.For reasons of standardization and comparability of results, only one type of prosthesis (medium-high range) will be provided.
The settings will be performed by audiologists of ENT service during the inclusion visit.
Surgical restoration of the columellar effect consists of the intraoperative verification of the stapedo-vestibular ankylosis which provides diagnostic.
Then a stapedotomy (laser or Ototool°) is performed and partial ossicular prosthesis s inserted between stapedotomy and the long process of the incus.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of the quality of life (scored by GHSI)
Time Frame: 4th Month
|
The primary outcome is to describe the evolution of the quality of life (scored by the Glasgow Health Status Inventory (GHSI)) during the hearing rehabilitation of otosclerosis frst with an external monaural hearing aid (support for at least 2 months), followed by a surgical treatment.
|
4th Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of the quality of life (scored by SSQ)
Time Frame: Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Secondary outcomes will be to describe the evolution of the quality of life by specific questionnaires (SSQ APHAB, GBI), the evolution of simple and complex audiometric testing in both managements of otosclerosis.
Adverse reactions reported are also analyzed as well as the number of patients refusing surgery after trying hearing aid rehabilitation.
|
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Evolution of the quality of life (scored by APHAB)
Time Frame: Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Secondary outcomes will be to describe the evolution of the quality of life by specific questionnaires (SSQ APHAB, GBI), the evolution of simple and complex audiometric testing in both managements of otosclerosis.
Adverse reactions reported are also analyzed as well as the number of patients refusing surgery after trying hearing aid rehabilitation.
|
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Evolution of the quality of life (scored by GBI)
Time Frame: Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Secondary outcomes will be to describe the evolution of the quality of life by specific questionnaires (SSQ APHAB, GBI), the evolution of simple and complex audiometric testing in both managements of otosclerosis.
Adverse reactions reported are also analyzed as well as the number of patients refusing surgery after trying hearing aid rehabilitation.
|
Change and evolution at different time points: baseline, 2-month intervention, 2-month after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mathieu MARX, MD, Toulouse University Hospital (CHU Toulouse)
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC31/14/7312
- 2014-A01764-43 (Other Identifier: ID-RCB)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Otosclerosis
-
Rennes University HospitalCompletedOtosclerosis | Otosclerosis SurgeryFrance
-
Mansoura UniversityCompleted
-
Karolinska University HospitalKarolinska Institutet; AstraZenecaCompleted
-
Sensoptic SACompletedOtosclerosis of Middle Ear | Cholesteatoma, Middle Ear | Disorder of Middle Ear
-
Central Hospital, Nancy, FranceNot yet recruitingOtosclerosisFrance
-
Pamukkale UniversityNot yet recruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Iuliu Hatieganu University of Medicine and PharmacyNot yet recruitingOtosclerosisRomania
-
Hospices Civils de LyonActive, not recruiting
-
Fondation Ophtalmologique Adolphe de RothschildTerminated
Clinical Trials on External hearing aid
-
Northwestern UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Completed
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Bernafon AGCompletedHearing LossSwitzerland
-
Sonova AGWestern UniversityRecruiting
-
Sonova AGCompletedHearing Loss, Sensorineural | Hearing Loss, BilateralCanada
-
Sonova AGCompleted
-
Sonova AGCompleted
-
Education University of Hong KongChinese University of Hong KongCompletedTinnitus, Subjective | Hearing ImpairmentHong Kong